Safety Information: Mane Max 5-in-1 is a prescription compounded medication containing dutasteride, minoxidil, biotin, vitamin D3, and vitamin K2. It should only be used as prescribed and under the supervision of a licensed healthcare provider. Individual results may vary.
Dutasteride may cause decreased libido, erectile dysfunction, ejaculation disorders, breast tenderness, and changes in PSA levels. Dutasteride is contraindicated during pregnancy due to the risk of harm to a developing male fetus. Pregnant individuals or those who may become pregnant should not handle broken or leaking dutasteride-containing tablets.
Oral minoxidil may cause dizziness, low blood pressure, rapid heartbeat, fluid retention, swelling, and unwanted hair growth. Rare but serious cardiovascular complications, including pericardial effusion, may occur. Patients with certain heart conditions or taking blood-pressure medications may require additional evaluation and monitoring.
Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Mane Max is prescribed following an evaluation by a licensed healthcare provider and prepared by a licensed compounding pharmacy when medically appropriate. The safety, absorption, and effectiveness of this specific five-ingredient sublingual formulation have not been established in clinical trials.
Medical treatment is subject to provider approval. Product formulation, packaging, and appearance may vary.
References:
*FDA prescribing information for Avodart® (dutasteride).
*FDA prescribing information for Loniten® (oral minoxidil).
*Olsen EA et al. The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss. Journal of the American Academy of Dermatology, 2006.
*Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. Journal of the American Academy of Dermatology, 2021.
*FDA guidance on compounded drugs and associated safety considerations.